Product Details for ANDA 202557
BUSPIRONE HYDROCHLORIDE (BUSPIRONE HYDROCHLORIDE)
5MG
Marketing Status: Prescription
7.5MG
Marketing Status: Prescription
10MG
Marketing Status: Prescription
15MG
Marketing Status: Prescription
30MG
Marketing Status: Prescription
5MG
Marketing Status: Prescription
Active Ingredient: BUSPIRONE HYDROCHLORIDE
Proprietary Name: BUSPIRONE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202557
Product Number: 001
Approval Date: Dec 30, 2014
Applicant Holder Full Name: ACCORD HEALTHCARE INC
Marketing Status: Prescription
Patent and Exclusivity Information
BUSPIRONE HYDROCHLORIDE (BUSPIRONE HYDROCHLORIDE)
Proprietary Name: BUSPIRONE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202557
Product Number: 001
Approval Date: Dec 30, 2014
Applicant Holder Full Name: ACCORD HEALTHCARE INC
Marketing Status: Prescription
Patent and Exclusivity Information
7.5MG
Marketing Status: Prescription
Active Ingredient: BUSPIRONE HYDROCHLORIDE
Proprietary Name: BUSPIRONE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 7.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202557
Product Number: 002
Approval Date: Dec 30, 2014
Applicant Holder Full Name: ACCORD HEALTHCARE INC
Marketing Status: Prescription
Patent and Exclusivity Information
BUSPIRONE HYDROCHLORIDE (BUSPIRONE HYDROCHLORIDE)
Proprietary Name: BUSPIRONE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 7.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202557
Product Number: 002
Approval Date: Dec 30, 2014
Applicant Holder Full Name: ACCORD HEALTHCARE INC
Marketing Status: Prescription
Patent and Exclusivity Information
10MG
Marketing Status: Prescription
Active Ingredient: BUSPIRONE HYDROCHLORIDE
Proprietary Name: BUSPIRONE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202557
Product Number: 003
Approval Date: Dec 30, 2014
Applicant Holder Full Name: ACCORD HEALTHCARE INC
Marketing Status: Prescription
Patent and Exclusivity Information
BUSPIRONE HYDROCHLORIDE (BUSPIRONE HYDROCHLORIDE)
Proprietary Name: BUSPIRONE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202557
Product Number: 003
Approval Date: Dec 30, 2014
Applicant Holder Full Name: ACCORD HEALTHCARE INC
Marketing Status: Prescription
Patent and Exclusivity Information
15MG
Marketing Status: Prescription
Active Ingredient: BUSPIRONE HYDROCHLORIDE
Proprietary Name: BUSPIRONE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 15MG
Reference Listed Drug: No
Reference Standard: Yes
TE Code: AB
Application Number: A202557
Product Number: 004
Approval Date: Dec 30, 2014
Applicant Holder Full Name: ACCORD HEALTHCARE INC
Marketing Status: Prescription
Patent and Exclusivity Information
BUSPIRONE HYDROCHLORIDE (BUSPIRONE HYDROCHLORIDE)
Proprietary Name: BUSPIRONE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 15MG
Reference Listed Drug: No
Reference Standard: Yes
TE Code: AB
Application Number: A202557
Product Number: 004
Approval Date: Dec 30, 2014
Applicant Holder Full Name: ACCORD HEALTHCARE INC
Marketing Status: Prescription
Patent and Exclusivity Information
30MG
Marketing Status: Prescription
Active Ingredient: BUSPIRONE HYDROCHLORIDE
Proprietary Name: BUSPIRONE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 30MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202557
Product Number: 005
Approval Date: Dec 30, 2014
Applicant Holder Full Name: ACCORD HEALTHCARE INC
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: BUSPIRONE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 30MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202557
Product Number: 005
Approval Date: Dec 30, 2014
Applicant Holder Full Name: ACCORD HEALTHCARE INC
Marketing Status: Prescription
Patent and Exclusivity Information